Cancer Prevention Pharmaceuticals
Broadcasting · Arizona, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1760 E River Rd Ste 250, Tucson, Arizona...Phone Number
(520) 908-7774Website
www.canprevent.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Cancer Prevention Pharmaceuticals
CanPrevent is a trusted source of health education information that aims to help individuals prevent diseases and lead healthier lives. The company provides easily understandable and educational content, including guides and tips on various health topics. Its intended clients are individuals seeking to improve their health knowledge and practices. CanPrevent focuses on delivering practical advice and insights related to nutrition, exercise, and overall wellness.Explore more
Cancer Prevention Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cancer Prevention Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Cancer Prevention Pharmaceuticals has new funding data
Congratulate Masked Content for being promoted to Masked Content at Cancer Prevention Pharmaceuticals
Check out if Cancer Prevention Pharmaceuticals is spiking on competitors!
Click to see if Cancer Prevention Pharmaceuticals had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Cancer Prevention Pharmaceuticals recently announced quarterly report
Product Launch: Get notified when Cancer Prevention Pharmaceuticals launches new products
Website visits: Recent activity has been detected on your website
Cancer Prevention Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Cancer Prevention Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Cancer Prevention Pharmaceuticals as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Cancer Prevention Pharmaceuticals is experiencing very low activity levels compared to other companies in the Media & Internet sector.
What does this means?
Cancer Prevention Pharmaceuticals is drawing exceptional interest within the Media & Internet industry, suggesting notable developments or strong market momentum, learn more about Cancer Prevention Pharmaceuticals.
Cancer Prevention Pharmaceuticals financials insights
Gather financial insights about Cancer Prevention Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2009
Debt
$1.3M
2011
Debt
$550K
2012
Private Equity
$4.3M
2015
Debt
$835K
2016
Debt
$5M
2017
Debt
$700K
Debt
$5M
2020
Debt
$150K
Cancer Prevention Pharmaceuticals Tech Stack
A closer look at the technologies used by Cancer Prevention Pharmaceuticals
Cancer Prevention Pharmaceuticals News & Media
Panbela Therapeutics, Inc. Closes Acquisition of Cancer Prevention Pharmaceuticals, Inc.
MINNEAPOLIS, June 16, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with cancer, today announced the closing of its acquisition of Cancer Prevention Pharmaceuticals, Inc. (CPP), a private clinical stage company developing therapeutics to reduce the risk and recurrence of cancer and rare diseases, for a combination of stock and future milestone payments.Panbela Therapeutics Acquires Cancer Prevention Pharmaceuticals For Stock & Milestone Payment
Panbela Therapeutics Inc (NASDAQ: PBLA) has read morePanbela Therapeutics, Inc. to Acquire Cancer Prevention Pharmaceuticals, Inc.
MINNEAPOLIS, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with cancer, today announced it has entered into a definitive agreement to acquire Cancer Prevention Pharmaceuticals, Inc. (“CPP”), a private clinical stage company developing therapeutics to reduce the risk and recurrence of cancer and rare diseases, for a combination of stock and future milestone payments.Cancer Prevention Pharmaceuticals Announces NEJM Publication of Landmark Phase 3 Clinical Trial for Treatment of Familial Adenomatous Polyposis
TUCSON, Ariz.--(BUSINESS WIRE)--Cancer Prevention Pharmaceuticals, Inc. (CPP), a private biotech company developing novel therapeutics to prevent cancer and other diseases, today announced The New England Journal of Medicine (NEJM) has published results from its landmark FAP-310 Phase 3 clinical trial of CPP-1X/sul as a pharmaco-preventive treatment for adults with familial adenomatous polyposis (FAP). FAP is a rare genetic disease that if left untreated progresses to colorectal cancer in nearl
Read more news
Top Broadcasting Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cancer Prevention Pharmaceuticals
Sign Up For FreeTo access detailed company insights
CanPrevent is a trusted source of health education information that aims to help individuals prevent diseases and lead healthier lives. The company provides easily understandable and educational content, including guides and tips on various health topics. Its intended clients are individuals seeking to improve their health knowledge and practices.... Read More
